Enzobiotics—A Novel Therapy for the Elimination of Uremic Toxins in Patients with CKD (EETOX Study): A Multicenter Double-Blind Randomized Controlled Trial
Design, participants, setting, and measurements: Predialysis adult participants with chronic kidney disease (CKD) and mean estimated glomerular filtration rate (eGFR) <45 mL/min per 1.73 m<sup>2</sup>) were recruited in 2019 to a multicentric double-blinded randomized controlled trial...
Main Authors: | Anita Saxena, Sanjay Srinivasa, Ilangovan Veerappan, Chakko Jacob, Amol Mahaldar, Amit Gupta, Ananthasubramaniam Rajagopal |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/14/18/3804 |
Similar Items
-
The Effect of Dietary Protein Concentration on the Fecal Microbiome and Serum Concentrations of Gut-Derived Uremic Toxins in Healthy Adult Cats
by: Stacie Summers, et al.
Published: (2023-08-01) -
Microbe-derived uremic solutes enhance thrombosis potential in the host
by: Ina Nemet, et al.
Published: (2023-12-01) -
Effects of <i>p</i>-Cresol on Oxidative Stress, Glutathione Depletion, and Necrosis in HepaRG Cells: Comparisons to Other Uremic Toxins and the Role of <i>p</i>-Cresol Glucuronide Formation
by: Sang Zhu, et al.
Published: (2021-06-01) -
Possible Effects of Uremic Toxins p-Cresol, Indoxyl Sulfate, p-Cresyl Sulfate on the Development and Progression of Colon Cancer in Patients with Chronic Renal Failure
by: Rossella Di Paola, et al.
Published: (2023-06-01) -
Gut-Derived Uremic Toxins in CKD: An Improved Approach for the Evaluation of Serum Indoxyl Sulfate in Clinical Practice
by: Gianvito Caggiano, et al.
Published: (2023-03-01)